Modulação da resistência a drogas por Furocumarinas e Furocromonas em Staphylococcus aureus

Detalhes bibliográficos
Autor(a) principal: Rodrigues, Damara Freitas
Data de Publicação: 2022
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Biblioteca Digital de Teses e Dissertações da UFPB
Texto Completo: https://repositorio.ufpb.br/jspui/handle/123456789/26746
Resumo: Microbial resistance to antibiotics has become a worldwide crisis problem, requiring the search for inhibitors of resistance mechanisms that can re-establish the usefulness of these compounds. Furocoumarins and furochromones are natural substances with several important biological properties, such as antibacterial, anti-inflammatory, antitumor, and others. In the present work, substances from the class of furocoumarins and furochromones were evaluated as modulators of drug resistance by inhibition of bacterial efflux systems. The BHI broth microdilution technique was used to determine the minimum inhibitory concentration (MIC) of the compounds against Staphylococcus aureus strain SA-1199B overexpressing the NorA efflux protein. The compounds Ciprofloxacin, Norfloxacin, Ethidium bromide (EtBr), and Berberine were used as NorA substrates to evaluate the modulating action of the substances. No furocoumarin and furochromone tested showed relevant antibacterial activity (MIC ≥512 μg/mL) against S. aureus SA-1199B. However, all showed drug resistance modulating activity. In the modulation assay, the furocoumarins and furochromones were incorporated into the culture medium at subinhibitory concentration (¼ of the MIC). The furocoumarin Isosaxalin showed the best result, modulating 8-fold the minimum inhibitory concentration (MIC) of Norfloxacin, Heraclenol modulated 4-fold and the other furocoumarins (Psoralen, Angelicin, and 3-Carbethoxypsoralen) modulated 2-fold, both, for Norfloxacin and Ciprofloxacin. The furochromones Khellin and Visnagin modulated 2-fold the MIC of Norfloxacin and Ciprofloxacin. The modulation result was similar to EtBr and Berberine indicating that these substances are possible efflux pump inhibitors (EPIs). To understand the differences in their abilities to act as EPIs, a molecular docking study of the furocoumarins and furochromones against the NorA pump model was conducted. Through molecular docking it was possible to theoretically verify the interaction of these substances with the NorA pump, corroborating the microbiological study.
id UFPB_05e5f21b2f9477a6a3c55f63c2f30307
oai_identifier_str oai:repositorio.ufpb.br:123456789/26746
network_acronym_str UFPB
network_name_str Biblioteca Digital de Teses e Dissertações da UFPB
repository_id_str
spelling Modulação da resistência a drogas por Furocumarinas e Furocromonas em Staphylococcus aureusResistência antibióticaInibidores de bombas de efluxoNorADocagem molecularAntibiotic resistanceEfflux pump inhibitorsMolecular dockingCNPQ::CIENCIAS BIOLOGICAS::BIOLOGIA GERALMicrobial resistance to antibiotics has become a worldwide crisis problem, requiring the search for inhibitors of resistance mechanisms that can re-establish the usefulness of these compounds. Furocoumarins and furochromones are natural substances with several important biological properties, such as antibacterial, anti-inflammatory, antitumor, and others. In the present work, substances from the class of furocoumarins and furochromones were evaluated as modulators of drug resistance by inhibition of bacterial efflux systems. The BHI broth microdilution technique was used to determine the minimum inhibitory concentration (MIC) of the compounds against Staphylococcus aureus strain SA-1199B overexpressing the NorA efflux protein. The compounds Ciprofloxacin, Norfloxacin, Ethidium bromide (EtBr), and Berberine were used as NorA substrates to evaluate the modulating action of the substances. No furocoumarin and furochromone tested showed relevant antibacterial activity (MIC ≥512 μg/mL) against S. aureus SA-1199B. However, all showed drug resistance modulating activity. In the modulation assay, the furocoumarins and furochromones were incorporated into the culture medium at subinhibitory concentration (¼ of the MIC). The furocoumarin Isosaxalin showed the best result, modulating 8-fold the minimum inhibitory concentration (MIC) of Norfloxacin, Heraclenol modulated 4-fold and the other furocoumarins (Psoralen, Angelicin, and 3-Carbethoxypsoralen) modulated 2-fold, both, for Norfloxacin and Ciprofloxacin. The furochromones Khellin and Visnagin modulated 2-fold the MIC of Norfloxacin and Ciprofloxacin. The modulation result was similar to EtBr and Berberine indicating that these substances are possible efflux pump inhibitors (EPIs). To understand the differences in their abilities to act as EPIs, a molecular docking study of the furocoumarins and furochromones against the NorA pump model was conducted. Through molecular docking it was possible to theoretically verify the interaction of these substances with the NorA pump, corroborating the microbiological study.NenhumaA resistência microbiana aos antibióticos se tornou um problema de crise mundial, sendo necessária a busca por inibidores dos mecanismos de resistência que possam reestabelecer a utilidade desses compostos. As furocumarinas e furocromonas são substâncias naturais com diversas propriedades biológicas importantes, tais como, antibacteriana, anti-inflamatória, antitumoral, entre outras. No presente trabalho, foram avaliadas substâncias da classe das furocumarinas e furocromonas como moduladoras da resistência a drogas por inibição de sistemas de efluxo bacteriano. A técnica da microdiluição em caldo BHI foi utilizada para determinar a concentração inibitória mínima (CIM) dos compostos contra a linhagem Staphylococcus aureus SA-1199B que superexpressa a proteína de efluxo NorA. Os compostos Ciprofloxacino, Norfloxacino, Brometo de etídio (EtBr) e Berberina foram utilizados como substratos da NorA para avaliar a ação moduladora das substâncias. Nenhuma furocumarina e furocromona testada apresentou atividade antibacteriana relevante (CIM ≥512 μg/mL) contra S. aureus SA-1199B. Contudo, todas demonstraram atividade de modulação da resistência a drogas. No ensaio de modulação as furocumarinas e furocromonas foram incorporadas ao meio de cultura na concentração subinibitória (¼ da CIM). A furocumarina Isosaxalina apresentou o melhor resultado, reduzindo 8 vezes a CIM de Norfloxacino, o Heraclenol reduziu 4 vezes e as demais furocumarinas (Psoraleno, Angelicina e 3-Carbetoxipsoraleno) reduziram 2 vezes, ambos, a CIM de Norfloxacino e Ciprofloxacino. As furocromonas Quelina e Visnagina reduziram 2 vezes a CIM de Norfloxacino e Ciprofloxacino. O resultado de modulação foi semelhante com o EtBr e com a Berberina, indicando que essas substâncias são possíveis inibidoras de bombas de efluxo (EPIs). A fim de compreender as diferenças nas capacidades de atuar como EPIs, foi conduzido um estudo de docagem molecular das furocumarinas e furocromonas contra o modelo da bomba NorA. Por meio da docagem molecular foi possível verificar teoricamente a interação dessas substâncias com a bomba NorA, corroborando com o estudo microbiológico.Universidade Federal da ParaíbaBrasilBiologia Celular e MolecularPrograma de Pós-Graduação em Biologia Celular e MolecularUFPBSiqueira Júnior, José Pinto dehttp://lattes.cnpq.br/1016153148024105Gurgel, Ana Pavla Almeida Dinizhttp://lattes.cnpq.br/1857108893545275Rodrigues, Damara Freitas2023-04-18T14:54:05Z2022-12-132023-04-18T14:54:05Z2022-10-07info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesishttps://repositorio.ufpb.br/jspui/handle/123456789/26746porAttribution-NoDerivs 3.0 Brazilhttp://creativecommons.org/licenses/by-nd/3.0/br/info:eu-repo/semantics/openAccessreponame:Biblioteca Digital de Teses e Dissertações da UFPBinstname:Universidade Federal da Paraíba (UFPB)instacron:UFPB2023-04-19T06:04:03Zoai:repositorio.ufpb.br:123456789/26746Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufpb.br/PUBhttp://tede.biblioteca.ufpb.br:8080/oai/requestdiretoria@ufpb.br|| diretoria@ufpb.bropendoar:2023-04-19T06:04:03Biblioteca Digital de Teses e Dissertações da UFPB - Universidade Federal da Paraíba (UFPB)false
dc.title.none.fl_str_mv Modulação da resistência a drogas por Furocumarinas e Furocromonas em Staphylococcus aureus
title Modulação da resistência a drogas por Furocumarinas e Furocromonas em Staphylococcus aureus
spellingShingle Modulação da resistência a drogas por Furocumarinas e Furocromonas em Staphylococcus aureus
Rodrigues, Damara Freitas
Resistência antibiótica
Inibidores de bombas de efluxo
NorA
Docagem molecular
Antibiotic resistance
Efflux pump inhibitors
Molecular docking
CNPQ::CIENCIAS BIOLOGICAS::BIOLOGIA GERAL
title_short Modulação da resistência a drogas por Furocumarinas e Furocromonas em Staphylococcus aureus
title_full Modulação da resistência a drogas por Furocumarinas e Furocromonas em Staphylococcus aureus
title_fullStr Modulação da resistência a drogas por Furocumarinas e Furocromonas em Staphylococcus aureus
title_full_unstemmed Modulação da resistência a drogas por Furocumarinas e Furocromonas em Staphylococcus aureus
title_sort Modulação da resistência a drogas por Furocumarinas e Furocromonas em Staphylococcus aureus
author Rodrigues, Damara Freitas
author_facet Rodrigues, Damara Freitas
author_role author
dc.contributor.none.fl_str_mv Siqueira Júnior, José Pinto de
http://lattes.cnpq.br/1016153148024105
Gurgel, Ana Pavla Almeida Diniz
http://lattes.cnpq.br/1857108893545275
dc.contributor.author.fl_str_mv Rodrigues, Damara Freitas
dc.subject.por.fl_str_mv Resistência antibiótica
Inibidores de bombas de efluxo
NorA
Docagem molecular
Antibiotic resistance
Efflux pump inhibitors
Molecular docking
CNPQ::CIENCIAS BIOLOGICAS::BIOLOGIA GERAL
topic Resistência antibiótica
Inibidores de bombas de efluxo
NorA
Docagem molecular
Antibiotic resistance
Efflux pump inhibitors
Molecular docking
CNPQ::CIENCIAS BIOLOGICAS::BIOLOGIA GERAL
description Microbial resistance to antibiotics has become a worldwide crisis problem, requiring the search for inhibitors of resistance mechanisms that can re-establish the usefulness of these compounds. Furocoumarins and furochromones are natural substances with several important biological properties, such as antibacterial, anti-inflammatory, antitumor, and others. In the present work, substances from the class of furocoumarins and furochromones were evaluated as modulators of drug resistance by inhibition of bacterial efflux systems. The BHI broth microdilution technique was used to determine the minimum inhibitory concentration (MIC) of the compounds against Staphylococcus aureus strain SA-1199B overexpressing the NorA efflux protein. The compounds Ciprofloxacin, Norfloxacin, Ethidium bromide (EtBr), and Berberine were used as NorA substrates to evaluate the modulating action of the substances. No furocoumarin and furochromone tested showed relevant antibacterial activity (MIC ≥512 μg/mL) against S. aureus SA-1199B. However, all showed drug resistance modulating activity. In the modulation assay, the furocoumarins and furochromones were incorporated into the culture medium at subinhibitory concentration (¼ of the MIC). The furocoumarin Isosaxalin showed the best result, modulating 8-fold the minimum inhibitory concentration (MIC) of Norfloxacin, Heraclenol modulated 4-fold and the other furocoumarins (Psoralen, Angelicin, and 3-Carbethoxypsoralen) modulated 2-fold, both, for Norfloxacin and Ciprofloxacin. The furochromones Khellin and Visnagin modulated 2-fold the MIC of Norfloxacin and Ciprofloxacin. The modulation result was similar to EtBr and Berberine indicating that these substances are possible efflux pump inhibitors (EPIs). To understand the differences in their abilities to act as EPIs, a molecular docking study of the furocoumarins and furochromones against the NorA pump model was conducted. Through molecular docking it was possible to theoretically verify the interaction of these substances with the NorA pump, corroborating the microbiological study.
publishDate 2022
dc.date.none.fl_str_mv 2022-12-13
2022-10-07
2023-04-18T14:54:05Z
2023-04-18T14:54:05Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://repositorio.ufpb.br/jspui/handle/123456789/26746
url https://repositorio.ufpb.br/jspui/handle/123456789/26746
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv Attribution-NoDerivs 3.0 Brazil
http://creativecommons.org/licenses/by-nd/3.0/br/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NoDerivs 3.0 Brazil
http://creativecommons.org/licenses/by-nd/3.0/br/
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Universidade Federal da Paraíba
Brasil
Biologia Celular e Molecular
Programa de Pós-Graduação em Biologia Celular e Molecular
UFPB
publisher.none.fl_str_mv Universidade Federal da Paraíba
Brasil
Biologia Celular e Molecular
Programa de Pós-Graduação em Biologia Celular e Molecular
UFPB
dc.source.none.fl_str_mv reponame:Biblioteca Digital de Teses e Dissertações da UFPB
instname:Universidade Federal da Paraíba (UFPB)
instacron:UFPB
instname_str Universidade Federal da Paraíba (UFPB)
instacron_str UFPB
institution UFPB
reponame_str Biblioteca Digital de Teses e Dissertações da UFPB
collection Biblioteca Digital de Teses e Dissertações da UFPB
repository.name.fl_str_mv Biblioteca Digital de Teses e Dissertações da UFPB - Universidade Federal da Paraíba (UFPB)
repository.mail.fl_str_mv diretoria@ufpb.br|| diretoria@ufpb.br
_version_ 1801843008796098560